1-{4-[(3E)-3-{[(2-chloro-6-fluorophenyl)methoxy]imino}propanoyl]phenyl}-3,3-dimethylazetidin-2-one

Catalog No. :
ACEHDI701
CAS No. :
320422-73-9
Molecular Formula :
C21H20ClFN2O3
Molecular Weight :
402.85

IUPAC Name:(E)-3-(4-(3,3-dimethyl-2-oxoazetidin-1-yl)phenyl)-3-oxopropanal O-(2-chloro-6-fluorobenzyl) oxime

1-{4-[(3E)-3-{[(2-chloro-6-fluorophenyl)methoxy]imino}propanoyl]phenyl}-3,3-dimethylazetidin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$321.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-{4-[(3E)-3-{[(2-chloro-6-fluorophenyl)methoxy]imino}propanoyl]phenyl}-3,3-dimethylazetidin-2-one
IUPAC Name(E)-3-(4-(3,3-dimethyl-2-oxoazetidin-1-yl)phenyl)-3-oxopropanal O-(2-chloro-6-fluorobenzyl) oxime
Molecular FormulaC21H20ClFN2O3
Molecular Weight402.85
SMILESO=C1N(C2=CC=C(C(C/C=N/OCC3=C(F)C=CC=C3Cl)=O)C=C2)CC1(C)C
InChI KeyZCNNHNRBFRSVBE-BHGWPJFGSA-N
Synonym3-[4-(3,3-DIMETHYL-2-OXO-1-AZETANYL)PHENYL]-3-OXOPROPANAL O-(2-CHLORO-6-FLUOROBENZYL)OXIME;1-{4-[(3E)-3-{[(2-chloro-6-fluorophenyl)methoxy]imino}propanoyl]phenyl}-3,3-dimethylazetidin-2-one;Benzenepropanal, 4-(3,3-dimethyl-2-oxo-1-azetidinyl)-β-oxo-, 1-[O-[(2-chloro-6-fluorophenyl)methyl]oxime]
CAS No.320422-73-9

Synthetic Route by SureRoute

1. ACEHDI701 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEHDI701 route product structure diagram
    ACEHDI701320422-73-9
Inquiry

2. ACEHDI701 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEHDI701 route product structure diagram
    ACEHDI701320422-73-9
Inquiry

Comments (0)